Fetal Adrenal Suppression Due to Maternal Corticosteroid Use: Case Report
Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2011, Vol 3, Issue 3
Abstract
During pregnancy, steroids are usually used in maternal diseases such as adrenal failure or other autoimmune diseases, e.g. idiopathic thrombocytopenic purpura (ITP), Crohn’s disease, systemic lupus erythematosus, dermatomyositis, scleroderma, Addison’s disease and hyperemesis gravidarum, HELLP syndrome. Endogenous or exogenous maternal steroids are metabolized by the placental enzyme 11 beta-hydroxy steroid dehydrogenase type 2. Prednisolone and methylprednisolone are highly sensitive to this enzyme, while dexamethasone and betamethasone are less well metabolized. Steroids which can cross the placental barrier are administered in cases like fetal lupus, congenital adrenal hyperplasia and for enhancement of fetal lung maturation, whereas steroids used in maternal diseases are usually the ones with low affinity to the placenta; however, in case of long-term use or in high doses, placental enzyme saturation occurs and thus, resulting in fetal adrenal suppression. Antenatal steroids can lead to low birth weight, as observed in our patient. Here, we report a case with fetal adrenal suppression due to maternal methylprednisolone use presenting with early hypoglycaemia and late hyponatremia in neonatal period and requiring three-month replacement therapy.
Authors and Affiliations
Selim Kurtoğlu, Dilek Sarıcı, Mustafa Ali Akın, Ghaniya Daar, Levent Korkmaz, Şeyma Memur
Keywords
Related Articles
- EP ID EP85896
- DOI -
- Views 130
- Downloads 0
Neonatal Sludge: A finding of congenital hypothyroidism
Congenital hypothyroidism is one of the most urgent diseases of the neonate. When diagnosed and treated at an early stage, its most important complication, mental retardation, is preventable. The signs of congenital hypo...
Metabolic Syndrome in Childhood: defining the problem
There is a significant increase in the incidence of childhood obesity all over the world which frequently leads to Type 2 diabetes mellitus (T2DM). Several studies have focused on the definitive criteria for diagnosis of...
Combined Evaluation of IGF-1 and IGFBP-3 as an Index of Efficacy and Safety in Growth Hormone Treated Patients
Objective: Measurement of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels has been recommended as a useful index for monitoring of growth hormone (GH) therapy in GH deficient childre...
Evaluation of Permanent Growth Hormone Deficiency (GHD) in Young Adults with Childhood Onset GHD: A multicenter study
Background: Reconfirming the diagnosis of childhood onset growth hormone deficiency (GHD) in young adults is necessary to demonstrate the need for continuation of GH therapy. Objective: This nationally-based study was p...
Melnick-Needles Syndrome Associated with Growth Hormone Deficiency: A Case Report
Melnick-Needles syndrome is an X-linked dominant bone dysplasia characterized by a typical facies (exophthalmos, full cheeks, micrognathia, and malalignment of teeth), flaring of the metaphyses of long bones, s-like curv...